ReShape Lifesciences Inc. (RSLS)
USD 0.49
(29.26%)
USD 0.49
(29.26%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -110.88 USD | 98.25% |
| 2022 | -6316.20 USD | 61.58% |
| 2021 | -16.43 Thousand USD | 65.89% |
| 2020 | -48.19 Thousand USD | 64.86% |
| 2019 | -137.16 Thousand USD | 63.02% |
| 2018 | -370.87 Thousand USD | -110.71% |
| 2017 | -176 Thousand USD | 63.44% |
| 2016 | -481.39 Thousand USD | -262.44% |
| 2015 | -132.81 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 100.0% |
| 2012 | -1720.86 USD | 31.05% |
| 2011 | -2495.74 USD | 58.23% |
| 2010 | -5975.16 USD | 67.9% |
| 2009 | -18.61 Thousand USD | -185.33% |
| 2008 | -6523.84 USD | 80.75% |
| 2007 | -33.89 Thousand USD | 65.81% |
| 2006 | -99.14 Thousand USD | -18.61% |
| 2005 | -83.58 Thousand USD | -18.3% |
| 2004 | -70.65 Thousand USD | -103.78% |
| 2003 | -34.67 Thousand USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.09 USD | -29.14% |
| 2024 Q2 | -0.06 USD | 32.41% |
| 2023 Q3 | -1.02 USD | 5.56% |
| 2023 Q2 | -1.08 USD | 30.77% |
| 2023 Q1 | -1.56 USD | 95.6% |
| 2023 FY | - USD | 98.25% |
| 2023 Q4 | -0.07 USD | 92.9% |
| 2022 Q1 | -22.16 USD | 77.67% |
| 2022 Q2 | -24.45 USD | -10.33% |
| 2022 FY | - USD | 61.58% |
| 2022 Q4 | -35.46 USD | -31.28% |
| 2022 Q3 | -27.01 USD | -10.47% |
| 2021 Q2 | -42.84 USD | 30.95% |
| 2021 Q1 | -62.04 USD | 42.91% |
| 2021 Q3 | -51.79 USD | -20.89% |
| 2021 Q4 | -99.26 USD | -91.66% |
| 2021 FY | - USD | 65.89% |
| 2020 Q1 | -31.42 USD | 84.23% |
| 2020 FY | - USD | 64.86% |
| 2020 Q3 | -65.92 USD | -152.86% |
| 2020 Q4 | -108.68 USD | -64.87% |
| 2020 Q2 | -26.07 USD | 17.03% |
| 2019 Q3 | -5322.84 USD | 29.15% |
| 2019 Q2 | -7512.98 USD | -130.46% |
| 2019 FY | - USD | 63.02% |
| 2019 Q4 | -199.23 USD | 96.26% |
| 2019 Q1 | -3260.01 USD | -761.27% |
| 2018 Q3 | -1347.52 USD | 99.18% |
| 2018 FY | - USD | -110.71% |
| 2018 Q1 | -92.07 Thousand USD | -406064.31% |
| 2018 Q2 | -164.72 Thousand USD | -78.9% |
| 2018 Q4 | -378.51 USD | 71.91% |
| 2017 Q1 | -63.64 USD | 52.0% |
| 2017 Q3 | -786.66 USD | -15.03% |
| 2017 Q2 | -683.88 USD | -974.61% |
| 2017 Q4 | -22.67 USD | 97.12% |
| 2017 FY | - USD | 63.44% |
| 2016 Q4 | -132.59 USD | 77.48% |
| 2016 FY | - USD | -262.44% |
| 2016 Q2 | -1697.88 USD | 48.67% |
| 2016 Q1 | -3307.48 USD | -103908.81% |
| 2016 Q3 | -588.67 USD | 65.33% |
| 2015 Q1 | -73.97 USD | -1554.81% |
| 2015 Q4 | -3.18 USD | 89.38% |
| 2015 Q3 | -29.94 USD | 59.88% |
| 2015 Q2 | -74.63 USD | -0.89% |
| 2015 FY | - USD | 0.0% |
| 2014 Q1 | -5.13 USD | 4.11% |
| 2014 Q2 | -5.54 USD | -7.99% |
| 2014 Q4 | -4.47 USD | -7.71% |
| 2014 Q3 | -4.15 USD | 25.09% |
| 2014 FY | - USD | 0.0% |
| 2013 Q1 | -7.02 USD | 16.73% |
| 2013 Q2 | -5.68 USD | 19.09% |
| 2013 Q3 | -5.63 USD | 0.88% |
| 2013 Q4 | -5.35 USD | 4.97% |
| 2013 FY | - USD | 100.0% |
| 2012 Q1 | -7.66 USD | 86.75% |
| 2012 Q3 | -7.13 USD | -11.23% |
| 2012 Q4 | -8.43 USD | -18.23% |
| 2012 Q2 | -6.41 USD | 16.32% |
| 2012 FY | - USD | 31.05% |
| 2011 Q1 | -9.12 USD | 67.86% |
| 2011 Q2 | -9.96 USD | -9.21% |
| 2011 Q3 | -12.94 USD | -29.92% |
| 2011 Q4 | -57.81 USD | -346.75% |
| 2011 FY | - USD | 58.23% |
| 2010 Q3 | -29.32 USD | -2.95% |
| 2010 FY | - USD | 67.9% |
| 2010 Q1 | -32.91 USD | -58.68% |
| 2010 Q2 | -28.48 USD | 13.46% |
| 2010 Q4 | -28.38 USD | 3.21% |
| 2009 FY | - USD | -185.33% |
| 2009 Q4 | -20.74 USD | 82.69% |
| 2009 Q1 | -15.05 USD | 73.18% |
| 2009 Q2 | -103.50 USD | -587.71% |
| 2009 Q3 | -119.82 USD | -15.77% |
| 2008 Q4 | -56.12 USD | -85.46% |
| 2008 Q1 | -25.29 USD | 59.7% |
| 2008 Q2 | -33.77 USD | -33.53% |
| 2008 Q3 | -30.26 USD | 10.39% |
| 2008 FY | - USD | 80.75% |
| 2007 Q1 | -550.26 USD | -8.99% |
| 2007 Q3 | -550.26 USD | 0.0% |
| 2007 FY | - USD | 65.81% |
| 2007 Q4 | -62.76 USD | 88.59% |
| 2007 Q2 | -550.26 USD | 0.0% |
| 2006 FY | - USD | -18.61% |
| 2006 Q2 | -412.31 USD | 0.0% |
| 2006 Q4 | -504.85 USD | -22.44% |
| 2006 Q3 | -412.31 USD | 0.0% |
| 2006 Q1 | -412.31 USD | -1949.25% |
| 2005 Q2 | -360.29 USD | 0.0% |
| 2005 FY | - USD | -18.3% |
| 2005 Q1 | -360.29 USD | 0.0% |
| 2005 Q4 | -20.12 USD | 94.42% |
| 2005 Q3 | -360.29 USD | 0.0% |
| 2004 FY | - USD | -103.78% |
| 2003 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -4.94 USD | -2144.534% |
| BrainsWay Ltd. | -0.25 USD | -44252.0% |
| Cerus Corporation | -0.21 USD | -52700.0% |
| Envoy Medical, Inc. | -2.38 USD | -4558.824% |
| electroCore, Inc. | -3.42 USD | -3142.105% |
| Helius Medical Technologies, Inc. | -14.56 USD | -661.538% |
| IceCure Medical Ltd | -0.32 USD | -34550.0% |
| Inogen, Inc. | -4.42 USD | -2408.597% |
| OrthoPediatrics Corp. | -0.92 USD | -11952.174% |
| Lucid Diagnostics Inc. | -1.26 USD | -8700.0% |
| Monogram Orthopaedics, Inc. | -0.61 USD | -18077.049% |
| MaxCyte, Inc. | -0.37 USD | -29867.568% |
| NeuroOne Medical Technologies Corporation | -0.65 USD | -16958.462% |
| Nexalin Technology, Inc. | -0.63 USD | -17500.0% |
| Orthofix Medical Inc. | -4.12 USD | -2591.262% |
| PAVmed Inc | -9.16 USD | -1110.48% |
| Rapid Micro Biosystems, Inc. | -1.22 USD | -8988.525% |
| RxSight, Inc. | -1.41 USD | -7763.83% |
| Sight Sciences, Inc. | -1.14 USD | -9626.316% |
| SI-BONE, Inc. | -1.13 USD | -9712.389% |
| TELA Bio, Inc. | -2.04 USD | -5335.294% |
| Treace Medical Concepts, Inc. | -0.81 USD | -13588.889% |
| Vivos Therapeutics, Inc. | -11.14 USD | -895.332% |
| Acutus Medical, Inc. | -2.81 USD | -3845.907% |
| Talis Biomedical Corporation | -34.12 USD | -224.971% |
| Spectral AI, Inc. | -1.48 USD | -7391.892% |
| Nano-X Imaging Ltd. | -1.08 USD | -10166.667% |
| CVRx, Inc. | -1.99 USD | -5471.859% |
| DIH Holding US, Inc. Warrants | 0.09 USD | 122484.106% |
| PetVivo Holdings, Inc. | -0.78 USD | -14115.385% |
| Bioventus Inc. | -2.49 USD | -4353.012% |
| Venus Concept Inc. | -6.84 USD | -1521.053% |
| TriSalus Life Sciences, Inc. | -6.73 USD | -1547.548% |
| LivaNova PLC | 0.33 USD | 33700.0% |
| 908 Devices Inc. | -1.13 USD | -9712.389% |
| Alphatec Holdings, Inc. | -1.54 USD | -7100.0% |
| Nemaura Medical Inc. | -0.57 USD | -19352.632% |
| NeuroPace, Inc. | -1.27 USD | -8630.709% |
| LENSAR, Inc. | -1.31 USD | -8364.122% |
| Apyx Medical Corporation | -0.54 USD | -20433.333% |
| Cutera, Inc. | -8.19 USD | -1253.846% |
| STRATA Skin Sciences, Inc. | -3.10 USD | -3476.774% |
| BioSig Technologies, Inc. | -3.95 USD | -2707.089% |
| Anika Therapeutics, Inc. | -5.64 USD | -1865.957% |
| ClearPoint Neuro, Inc. | -0.90 USD | -12220.0% |
| Integra LifeSciences Holdings Corporation | 0.87 USD | 12844.828% |
| Axonics, Inc. | -0.12 USD | -92300.0% |
| Outset Medical, Inc. | -3.48 USD | -3086.207% |
| IRIDEX Corporation | -0.59 USD | -18693.22% |
| PROCEPT BioRobotics Corporation | -2.24 USD | -4850.0% |
| IRadimed Corporation | 1.36 USD | 8252.941% |
| Tivic Health Systems, Inc. | -10.40 USD | -966.154% |
| INVO Bioscience, Inc. | -5.13 USD | -2061.404% |
| Telesis Bio, Inc. | -1.64 USD | -6660.976% |
| Viemed Healthcare, Inc. | 0.27 USD | 41166.667% |
| Varex Imaging Corporation | -1.17 USD | -9376.923% |
| Quipt Home Medical Corp. | -0.07 USD | -153686.408% |
| Inspira Technologies Oxy B.H.N. Ltd. | -0.93 USD | -11822.581% |
| Pulmonx Corporation | -1.60 USD | -6830.0% |
| Dynatronics Corporation | -1.00 USD | -10988.0% |
| Modular Medical, Inc. | -0.78 USD | -14115.385% |
| Semler Scientific, Inc. | 3.06 USD | 3723.529% |
| InMode Ltd. | 2.37 USD | 4778.481% |
| Bruker Corporation | 2.92 USD | 3897.26% |
| Cytosorbents Corporation | -0.64 USD | -17225.0% |
| DexCom, Inc. | 1.44 USD | 7800.0% |
| Align Technology, Inc. | 5.82 USD | 2005.155% |
| Viveve Medical, Inc. | -2.65 USD | -4084.151% |
| ZimVie Inc. | -14.87 USD | -645.662% |
| Movano Inc. | -9.51 USD | -1065.931% |
| Cytek Biosciences, Inc. | -0.09 USD | -123374.388% |
| Nexalin Technology, Inc. | -0.63 USD | -17500.0% |
| DIH Holdings US, Inc. Class A Common Stock | 0.09 USD | 122484.106% |
| Tandem Diabetes Care, Inc. | -3.43 USD | -3132.653% |
| Profound Medical Corp. | -1.35 USD | -8113.333% |
| Insulet Corporation | 2.96 USD | 3845.946% |
| enVVeno Medical Corporation | -1.91 USD | -5705.236% |
| Surmodics, Inc. | -0.82 USD | -13421.951% |
| iCAD, Inc. | -0.27 USD | -40966.667% |
| Nuwellis, Inc. | -403.15 USD | 72.497% |
| Biotricity, Inc. | -1.66 USD | -6579.518% |
| iRhythm Technologies, Inc. | -4.04 USD | -2644.554% |
| Aethlon Medical, Inc. | -4.86 USD | -2181.481% |
| InspireMD, Inc. | -0.82 USD | -13421.951% |
| PAVmed Inc. | -9.16 USD | -1110.48% |
| BIOLASE, Inc. | -16.14 USD | -586.989% |
| Beyond Air, Inc. | -1.82 USD | -5992.308% |
| FONAR Corporation | 1.49 USD | 7541.611% |
| AxoGen, Inc. | -0.51 USD | -21641.176% |
| Vivani Medical, Inc. | -0.50 USD | -22076.0% |
| Tactile Systems Technology, Inc. | 1.24 USD | 9041.935% |
| Inari Medical, Inc. | -0.03 USD | -384900.0% |
| UFP Technologies, Inc. | 5.89 USD | 1982.513% |
| QT Imaging Holdings, Inc. | -0.54 USD | -20433.333% |
| Heart Test Laboratories, Inc. | -18.74 USD | -491.676% |
| Tenon Medical, Inc. | -68.71 USD | -61.374% |
| Autonomix Medical, Inc. Common Stock | -1.05 USD | -10460.0% |
| Co-Diagnostics, Inc. | -1.20 USD | -9140.0% |
| AdaptHealth Corp. | -5.32 USD | -1984.211% |
| Sintx Technologies, Inc. | -35.43 USD | -212.955% |
| NanoVibronix, Inc. | -2.12 USD | -5130.189% |
| Quanterix Corporation | -0.86 USD | -12793.023% |
| Inspira Technologies Oxy B.H.N. Ltd. | -0.93 USD | -11822.581% |
| Sensus Healthcare, Inc. | 0.03 USD | 372180.537% |
| Pacific Biosciences of California, Inc. | -1.21 USD | -9063.636% |
| TransMedics Group, Inc. | -0.77 USD | -14300.0% |
| ReWalk Robotics Ltd. | -2.59 USD | -4181.081% |
| NeuroMetrix, Inc. | -6.27 USD | -1668.421% |
| Hyperfine, Inc. | -0.62 USD | -17783.871% |
| Establishment Labs Holdings Inc. | -3.07 USD | -3511.726% |
| Biomerica, Inc. | -0.36 USD | -30700.0% |
| Bone Biologics Corporation | -34.01 USD | -226.022% |
| AVITA Medical, Inc. | -1.57 USD | -6962.42% |
| Bluejay Diagnostics, Inc. | -72.62 USD | -52.685% |
| Silk Road Medical, Inc | -1.44 USD | -7600.0% |